Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma

Liver Transplantation

Volumn 11, Issue 7, 2005, Pages 767-775

  Decaens, Thomas ^a,b   Roudot Thoraval, Françoise ^a   Bresson Hadni, Solange ^c   Meyer, Carole ^d   Gugenheim, Jean ^e   Durand, Francois ^f   Bernard, Pierre Henri ^g   Boillot, Olivier ^h   Boudjema, Karim ⁱ   Calmus, Yvon ^j   Hardwigsen, Jean ^k   Ducerf, Christian ^l   Pageaux, Georges Philippe ^m   Dharancy, Sebastien ⁿ   Chazouilleres, Olivier ^o   Dhumeaux, Daniel ^a   Cherqui, Daniel ^a   Duvoux, Christophe ^a,p  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f BEAUJON HOSPITAL   (France)

^g HÔPITAL PELLEGRIN   (France)

^h EDOUARD HERRIOT HOSPITAL   (France)

ⁱ PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^k HÔPITAL DE LA CONCEPTION   (France)

^l CROIX ROUSSE HOSPITAL   (France)

^m HÔPITAL SAINT ELOI   (France)

ⁿ LILLE UNIVERSITY HOSPITAL   (France)

^o HÔPITAL SAINT ANTOINE   (France)

^p INSERM   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CISPLATIN; CYCLOSPORIN A; DOXORUBICIN; EPIRUBICIN; GELFOAM; IODINATED POPPYSEED OIL; LIPIODOL ULTRAFLUIDE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CALCULATION; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DEMOGRAPHY; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; SURVIVAL TIME; TUMOR NECROSIS; TUMOR VOLUME;

EID: 22144488782     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20418     Document Type: Article

References (33)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
2. Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998;351:214-215.
3. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350:1142-1143.
4. Olthoff KM. Surgical options for hepatocellular carcinoma: resection and transplantation. Liver Transpl Surg 1998;4:S98-104.
5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
6. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
7. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999;19:311-322.
8. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, et al. A follow-up analysis of the pattern and predictors of drop-out from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003;9:684-692.
9. Lin DY, Liaw YF, Lee TY, Lai CM. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma - a randomized controlled trial. Gastroenterology 1988;94:453-456.
10. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990;11:181-184.
11. Madden MV, Krige JE, Bailey S, Beningfield SJ, Geddes C, Werner ID, et al. Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 1993;34:1598-1600.
12. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 1994;74:16-24.
13. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med 1995;332:1256-1261.
14. Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 1998;29:129-134.
15. Karlson BM, Lofberg AM, Lorelius LE, Jacobson G, Haglund U. Intraarterial chemoembolisation with lipiodol and epirubicin in hepatocellular cancer improved survival in some patients? Ann Chir Gynaecol 1999;88:264-268.
16. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
17. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002;224:47-54.
18. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171.
19. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003;37:429-442.
20. Oldhafer KJ, Chavan A, Fruhauf NR, Flemming P, Schlitt HJ, Kubicka S, et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 1998;29:953-959.
21. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-701.
22. Veltri A, Grosso M, Martina MC, Ciancio A, David E, Salizzoni M, et al. Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study. Cardiovasc Intervent Radiol 1998;21:393-398.
23. Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003;9:557-563.
24. Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999;5:192-199.
25. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, et al. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg 1995; 1:242-248.
26. Spreafico C, Marchiano A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994;192:687-690.
27. Morino M, Miglietta C, Grosso M, De Giuli M, Bismuth H. Preoperative chemoembolization for hepatocellular carcinoma. J Surg Oncol Suppl 1993;3:91-93.
28. Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg, 2002; 235:p. 533-539.
29. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Wolf P, Gugenheim J, Durand F, et al. Factors associated with recurrence after transplantation for hepatocellular carcinoma. J Hepatol 2003;38:12.
30. American Liver Tumor Study Group. A randomized prospective multiinstutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigator Booklet and Protocol; 1998.
31. Karnofsky DA. Palliation and life prolongation with anticancer drugs. CA Cancer J Clin 1966;16:117-119.
32. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998;27:1572-1577.
33. Etablissement Français de Greffes. Rapport d'activité et bilan des activités deprélèvementet de greffe en France. 2003.